T. van der Vlugt

Statistical Considerations for the Efficacy Assessment of Clinical Studies of Vulvar and Vaginal Atrophy

A. Orencia, Ling Chen, M. Ng, 2010 .

Epidemiological surveillance in Peace Corps Volunteers: a model for monitoring health in temporary residents of developing countries.

P. Graitcer, T. van der Vlugt, J. Moran, 1989, International journal of epidemiology.

Human immunodeficiency virus infection among Peace Corps volunteers in Zaire. No evidence for unusual modes of transmission.

H. Francis, T. van der Vlugt, M. Cappello, 1991, Archives of internal medicine.

FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.

S. R. Slaughter, Hylton V. Joffe, T. van der Vlugt, 2014, The New England journal of medicine.

The Clinical Use of Erythrocyte Sedimentation Rate in Pyogenic Vertebral Osteomyelitis

E. Carragee, T. van der Vlugt, David Kim, 1997, Spine.

The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine.

K. Miller, D. Fishbein, T. van der Vlugt, 1986, The American journal of tropical medicine and hygiene.

Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance

S. R. Slaughter, W. Liu, J. Weissfeld, 2017, Menopause.

Advantages of orals outweigh disadvantages.

T. van der Vlugt, P. Piotrow, S. C. Huber, 1975, Population reports. Series A, Oral contraceptives.